Z-1907-2019 Class II Terminated

Recalled by Phadia Ab — Uppsala, N/A

FDA device recall Z-1907-2019 was initiated by Phadia Ab on May 10, 2019 and is designated Class II. Reason for recall: Potential for reporting low assay results The recall status is terminated (terminated Jun 2, 2020). Affected quantity: 30 kits.

Recall details

Product Type
Devices
Report Date
Jul 10, 2019
Initiation Date
May 10, 2019
Termination Date
Jun 2, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
30 kits

Product description

EliA RF IgM Well, REF 14-5600-01 Product Usage: Usage: EliA RF IgM is intended for the in vitro quantitative measurement of IgM class rheumatoid factor antibodies in human serum and plasma (Li-heparin and EDTA) to aid in the diagnosis of rheumatoid arthritis in conjunction with other laboratory and clinical findings. EliA RF IgM uses the EliA IgM method on the instrument Phadia 100, Phadia 250, Phadia 2500 and Phadia 5000.

Reason for recall

Potential for reporting low assay results

Distribution pattern

US Nationwide n the states of NJ, NY, MI, WV, TX including PR

Code information

UDI (01) 07333066010854 (17) 200630 (10) 0085 Lot Number - 0085

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1907-2019
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Phadia Ab? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for Z-1907-2019. Report a data issue: hello@regdatalab.com.